Medication info
Augmentin 625 mg Tablets (Amoxicillin/Clavulanate Potassium (4:1))

Augmentin 625 mg Tablets (Amoxicillin/Clavulanate Potassium (4:1))

Prescription medicationTabletOral
Ingredient · strength
Amoxicillin Hydrate›500mg / 1 tabletDilute Potassium Clavulanate›212.73mg / 1 tablet
Manufacturer / importer
The U Pharmaceutical Co., Ltd.
Appearance
White or almost white oval film-coated tablets
Packaging
40 tablets/box [4 tablets/PTP × 10]
Approval status
Active

MFDS item code 201907725 · Approved 2019.11.05 · Insurance code 057000300

Summary

Main use
Treatment of respiratory, ear, nose and throat, dental, genitourinary, skin, soft-tissue, and bone infections
Who takes it
Adults · Children
Adult dose
The dose of this medicine should be determined based on the patient's age, body weight, renal function, and the severity of the infection. Administer at the start of a meal to minimize potential gastrointestinal intolerance. Absorption of amoxicillin/clavulanate is optimized when administered at the start of a meal. ○ Adults: Administer amoxicillin/potassium clavulanate 250 mg/125 mg per dose orally 3 times daily, every 8 hours; for severe infections and respiratory tract infections, the dose may be increased to amoxicillin/potassium clavulanate 500 mg/125 mg per dose. ○ In patients with renal impairment, adjust the dose as appropriate according to creatinine clearance. - Adults: Dose adjustments are based on the maximum recommended dose of amoxicillin. No dose adjustment is required for patients with creatinine clearance (CrCl) of 30 mL/min or greater. 10 ~ 30 mL/min: Administer amoxicillin/potassium clavulanate 250mg/125mg or amoxicillin/potassium clavulanate 500mg/125mg per dose every 12 hours. 10 mL/min or less: Administer amoxicillin/potassium clavulanate 250mg/125mg or amoxicillin/potassium clavulanate 500mg/125mg per dose every 24 hours. Hemodialysis: Administer amoxicillin/potassium clavulanate 250mg/125mg or amoxicillin/potassium clavulanate 500mg/125mg per dose every 24 hours, administer an additional dose during dialysis, and repeat the dose at the end of dialysis. (This is because serum concentrations of both amoxicillin and clavulanate decrease.)
Child dose
○ Children aged 12 years or older or weighing 40 kg or more: Administer amoxicillin/potassium clavulanate 250 mg/125 mg per dose orally 3 times daily, every 8 hours; for severe infections and respiratory tract infections, the dose may be increased to amoxicillin/potassium clavulanate 500 mg/125 mg per dose. - Children: Reduce the dose in the same manner.

Ingredients

Manufacturer
The U Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment of respiratory, ear, nose and throat, dental, genitourinary, skin, soft-tissue, and bone infections

  • Acute and chronic bronchitis
  • lobar and bronchopneumonia
  • empyema
  • lung abscess
  • tonsillitis
  • sinusitis
  • otitis media
  • cystitis
  • urethritis
  • pyelonephritis
  • pelvic inflammatory disease
  • gonorrhea
View approved original text

This medication is used to treat various bacterial infections. It is effective for respiratory infections such as acute and chronic bronchitis, lobar pneumonia, bronchopneumonia, empyema, lung abscess, tonsillitis, sinusitis, and otitis media. It is also used for urinary tract infections such as cystitis, urethritis, and pyelonephritis, as well as for gonorrhea and pelvic inflammatory disease. Skin and soft tissue infections including boils, abscesses, soft tissue infections, and wound infections can be treated, and it is also helpful for osteomyelitis and dental infections. This drug is reliable for treating infections as it is effective against various bacteria, including resistant strains that produce beta-lactamase. Therefore, patients should be aware that this drug is effective for treating various infectious diseases.

How to take

Adult dose

The dose of this medicine should be determined based on the patient's age, body weight, renal function, and the severity of the infection. Administer at the start of a meal to minimize potential gastrointestinal intolerance. Absorption of amoxicillin/clavulanate is optimized when administered at the start of a meal. ○ Adults: Administer amoxicillin/potassium clavulanate 250 mg/125 mg per dose orally 3 times daily, every 8 hours; for severe infections and respiratory tract infections, the dose may be increased to amoxicillin/potassium clavulanate 500 mg/125 mg per dose. ○ In patients with renal impairment, adjust the dose as appropriate according to creatinine clearance. - Adults: Dose adjustments are based on the maximum recommended dose of amoxicillin. No dose adjustment is required for patients with creatinine clearance (CrCl) of 30 mL/min or greater. 10 ~ 30 mL/min: Administer amoxicillin/potassium clavulanate 250mg/125mg or amoxicillin/potassium clavulanate 500mg/125mg per dose every 12 hours. 10 mL/min or less: Administer amoxicillin/potassium clavulanate 250mg/125mg or amoxicillin/potassium clavulanate 500mg/125mg per dose every 24 hours. Hemodialysis: Administer amoxicillin/potassium clavulanate 250mg/125mg or amoxicillin/potassium clavulanate 500mg/125mg per dose every 24 hours, administer an additional dose during dialysis, and repeat the dose at the end of dialysis. (This is because serum concentrations of both amoxicillin and clavulanate decrease.)

Child dose

○ Children aged 12 years or older or weighing 40 kg or more: Administer amoxicillin/potassium clavulanate 250 mg/125 mg per dose orally 3 times daily, every 8 hours; for severe infections and respiratory tract infections, the dose may be increased to amoxicillin/potassium clavulanate 500 mg/125 mg per dose. - Children: Reduce the dose in the same manner.

Precautions

This drug is a beta-lactam antibiotic and should not be administered to patients with hypersensitivity to penicillin or cephalosporin drugs. It should particularly be avoided in patients with infectious mononucleosis or lymphocytic leukemia due to a higher risk of rash. Patients with liver dysfunction should use this drug with caution as liver dysfunction may occur again. Patients with liver disease or moderate to severe renal impairment may experience increased concentrations of this drug, so dosage and administration intervals need adjustment. Patients with allergic tendencies or those with a history of asthma, urticaria, etc., should use this drug cautiously. Patients who cannot take oral medication, elderly patients, or those in poor general condition should be aware that vitamin K deficiency symptoms may occur. Patients with gastrointestinal diseases accompanied by vomiting or diarrhea may have reduced absorption of the drug; thus, their conditions must be checked before administration. This medication may cause gastrointestinal side effects such as diarrhea, nausea, vomiting, and abdominal pain, but gastrointestinal adverse reactions may be alleviated by taking the drug with meals. Liver dysfunction may occur, especially in elderly and male patients, so regular liver function tests are recommended. Rarely, serious skin reactions or hypersensitivity reactions such as anaphylaxis may occur; if rash or itching develops, administration should be stopped immediately and medical advice sought. Blood disorders such as leukopenia or thrombocytopenia may arise, so symptoms should be monitored carefully. Neurological symptoms such as anxiety, drowsiness, and seizures have been reported rarely, and caution is especially needed in patients with renal impairment. Renal dysfunction or symptoms of acute renal failure may occur, so regular renal function testing is recommended. This drug may affect the intestinal microbiota, leading to infections such as stomatitis or candidiasis; if symptoms occur, they should be reported immediately. There may be a risk of bleeding tendency due to vitamin K deficiency; therefore, long-term administration should be confirmed by blood tests. This drug may interact with other medications; especially if taking anticoagulants, antibiotics, or anti-inflammatory drugs, patients should inform their doctor. Use during pregnancy or breastfeeding is restricted, and it is particularly advisable to avoid this drug during the first trimester of pregnancy. If taken by nursing mothers, diarrhea or allergic reactions may occur in infants, so administration should be stopped if any unusual symptoms appear. It is not recommended for children under 12 years of age or weighing less than 40 kg. Elderly patients, due to decreased physiological function, are at higher risk for side effects, so careful observation and adjustment of dosage and administration intervals are necessary. In case of overdose, gastrointestinal symptoms, renal failure, seizures, etc., may occur, and immediate cessation of administration and appropriate emergency measures should be taken. This medication should be stored in a cool, dry place below 25 degrees Celsius, and care should be taken not to use it longer than necessary. If any unusual symptoms such as diarrhea, abdominal pain, or skin rash occur during use, immediate consultation with a physician is advised, and if serious reactions like anaphylaxis are suspected, rapid emergency treatment should be sought.

Side effects

Diarrhea, pseudomembranous colitis, indigestion, stomatitis, gastritis, glossitis, black hairy tongue, nausea, vomiting, loss of appetite, abdominal pain, abdominal distension, constipation, colonic pain, hyperacidity, diarrhea, dry mouth, acute pancreatitis, candidiasis, antibiotic-induced colitis, bloody stools, itching, erythema multiforme, Stevens-Johnson syndrome, toxic epidermal necrolysis, vesicular exfoliative dermatitis, acute generalized exanthematous pustulosis, eosinophilia, angioedema, anaphylaxis, serum sickness syndrome, hypersensitivity vasculitis, bronchospasm, dyspnea, laryngeal edema, anaphylactic shock, leukopenia, thrombocytopenia, hemolytic anemia, anemia, thrombocytopenic purpura, eosinophilia, leukemia, agranulocytosis, lymphocytopenia, thrombocytosis, bone marrow suppression, prolonged bleeding time, prolonged prothrombin time, vaginal itching, burning, increased secretion, anxiety, agitation, behavioral changes, confusion, drowsiness, insomnia, hyperactivity, dizziness, headache, seizures, antiparkinsonian agents, fever, aseptic meningitis, acute renal failure, interstitial nephritis, hematuria, crystalluria, symptoms of vitamin K deficiency, symptoms of vitamin B complex deficiency, linear IgA disease, taste disturbances, malaise, dermatitis, oral edema, stomach pain, fluid and electrolyte imbalance, rash, hyperactivity, drowsiness, decreased urination, renal failure, epileptic seizures, anaphylactic shock

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly closed container to prevent moisture, in a cool place between 1 and 25 degrees Celsius. Storing in this way helps maintain the medication's effectiveness.

Appearance and packaging

Appearance

White or almost white oval film-coated tablets

Package unit

40 tablets/box [4 tablets/PTP × 10]

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.